The role of mucociliary dysfunction in bronchial asthma

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Abnormalities of mucociliary function in the airways of patients with bronchial asthma are suggested by the clinical observation of excessive tracheobronchial secretions which are difficult to expectorate and may contribute to bronchial obstruction. Pathologic and functional studies in animals and patients have demonstrated an impairment of mucociliary transport mechanisms, but the pathogenesis of this abnormality is still poorly understood. In patients with allergic asthma, the elaboration of chemical mediators in the lung seems to depress mucociliary function. Although pharmacologic agents which increase mucous transport rates have been identified, more potent stimulators will probably be needed to produce a clinical improvement in patients with bronchial asthma.

Original languageEnglish
Pages (from-to)477-485
Number of pages9
JournalThe American Journal of Medicine
Volume67
Issue number3
DOIs
StatePublished - Jan 1 1979
Externally publishedYes

Fingerprint

Asthma
Mucociliary Clearance
Observation
Lung

ASJC Scopus subject areas

  • Nursing(all)

Cite this

The role of mucociliary dysfunction in bronchial asthma. / Wanner, Adam.

In: The American Journal of Medicine, Vol. 67, No. 3, 01.01.1979, p. 477-485.

Research output: Contribution to journalArticle

@article{ddadc97db8f3430280671afdc7e147fc,
title = "The role of mucociliary dysfunction in bronchial asthma",
abstract = "Abnormalities of mucociliary function in the airways of patients with bronchial asthma are suggested by the clinical observation of excessive tracheobronchial secretions which are difficult to expectorate and may contribute to bronchial obstruction. Pathologic and functional studies in animals and patients have demonstrated an impairment of mucociliary transport mechanisms, but the pathogenesis of this abnormality is still poorly understood. In patients with allergic asthma, the elaboration of chemical mediators in the lung seems to depress mucociliary function. Although pharmacologic agents which increase mucous transport rates have been identified, more potent stimulators will probably be needed to produce a clinical improvement in patients with bronchial asthma.",
author = "Adam Wanner",
year = "1979",
month = "1",
day = "1",
doi = "10.1016/0002-9343(79)90797-6",
language = "English",
volume = "67",
pages = "477--485",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - The role of mucociliary dysfunction in bronchial asthma

AU - Wanner, Adam

PY - 1979/1/1

Y1 - 1979/1/1

N2 - Abnormalities of mucociliary function in the airways of patients with bronchial asthma are suggested by the clinical observation of excessive tracheobronchial secretions which are difficult to expectorate and may contribute to bronchial obstruction. Pathologic and functional studies in animals and patients have demonstrated an impairment of mucociliary transport mechanisms, but the pathogenesis of this abnormality is still poorly understood. In patients with allergic asthma, the elaboration of chemical mediators in the lung seems to depress mucociliary function. Although pharmacologic agents which increase mucous transport rates have been identified, more potent stimulators will probably be needed to produce a clinical improvement in patients with bronchial asthma.

AB - Abnormalities of mucociliary function in the airways of patients with bronchial asthma are suggested by the clinical observation of excessive tracheobronchial secretions which are difficult to expectorate and may contribute to bronchial obstruction. Pathologic and functional studies in animals and patients have demonstrated an impairment of mucociliary transport mechanisms, but the pathogenesis of this abnormality is still poorly understood. In patients with allergic asthma, the elaboration of chemical mediators in the lung seems to depress mucociliary function. Although pharmacologic agents which increase mucous transport rates have been identified, more potent stimulators will probably be needed to produce a clinical improvement in patients with bronchial asthma.

UR - http://www.scopus.com/inward/record.url?scp=0018682893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018682893&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(79)90797-6

DO - 10.1016/0002-9343(79)90797-6

M3 - Article

C2 - 382847

AN - SCOPUS:0018682893

VL - 67

SP - 477

EP - 485

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -